Have you or a loved one developed serious lung problems after taking Entyvio? If so, you may be entitled to compensation by filing an Entyvio lawsuit. Contact the lawyers at Johnson//Becker for a free case review.
Entyvio (vedolizumab) is a drug used to treat Ulcerative Colitis. Entyvio is given as an IV infusion every few weeks. It is manufactured by Takeda Pharmaceuticals America, Inc. and was trademarked by Millennium Pharmaceuticals, Inc. The Ulcerative Colitis drug was first approved by the U.S. Food & Drug Administration in 2014.
Entyvio Lung Problems
There have been reports in the medical literature of Entyvio lung side effects including Interstitial Lung Disease, which is essentially an umbrella term of fibrosis of the lungs that leads to shortness of breath.
Here are some of the more recent articles associating the use of Entivio with serious lung issues.
- Pulmonary Manifestation of Crohn’s Disease Developed Under Treatment With Vedolizumab
- New-Onset Diffuse Parenchymal Lung Disease in a 52-Year-Old Woman With Ulcerative Colitis
- Vedolizumab-associated diffuse interstitial lung disease in patients with ulcerative colitis: A case report
- Crohn’s Disease with Atypical Extra-Intestinal Manifestations Developing Under Treatment with Vedolizumab.
Questions About an Entyvio Lawsuit? Contact a Johnson//Becker Lawyer for a Free Case Review.
If you or a loved one have been diagnosed with a serious lung side effect after taking Entyvio, you are not alone. You may be entitled to financial compensation for your injuries by filing an Entyvio lawsuit.
We offer a Free Case Evaluation. Please contact us using the form below or by calling us at (800) 279-6386.
We would be honored to speak with you and respond promptly to every inquiry we receive.